XIGDUO XR 5 mg/1

Xigduo XR 5 mg/1 combines dapagliflozin and metformin hydrochloride for extended-release oral administration. This medication is designed to support blood sugar management in adults with type 2 diabetes. It combines two active ingredients to help control glucose levels effectively.

Xigduo XR 5 mg/1 is primarily used for managing type 2 diabetes in adults. This combination medication works by improving insulin sensitivity and reducing glucose absorption in the intestines. It is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise. The extended-release formulation helps maintain steady blood sugar levels throughout the day.

Common effects of Xigduo XR 5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when first starting the medication. Some users may experience increased urination due to the dapagliflozin component. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Xigduo XR 5 mg/1 should be taken exactly as directed, typically with the evening meal to minimize gastrointestinal side effects. It is important to stay hydrated while using this medication. Patients with kidney problems or a history of metabolic acidosis should consult their healthcare provider before starting this treatment. Always follow the advice of a healthcare professional regarding the use of this medication.

Xigduo XR 5 mg/1 may interact with certain medications, including diuretics, corticosteroids, and some blood pressure medications. Alcohol consumption should be limited, as it can increase the risk of lactic acidosis. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.